Kintor Pharmaceuticals ha appena ricevuto l'approvazione della domanda IND per il loro nuovo farmaco GT20029 dall'NMPA
http://gamma.euroland.com/tools/ch/?app=news&at=ATTOPEN&oid=3868135&l=EN&na=ami062@uit.no&ru=http://asia.tools.euroland.com/tools/subscriptioncentre2/tracker/attachment /? atid = 1280030 & url = SG9uZ0tvbmdcRXRuZXRcMjAyMS0wMlxIS0VYLUVQU18yMDIxMDIwMV85NjA4ODg5XzAuUERG & companycode = KY-9939 & isstockexchangerelease = 1
http://gamma.euroland.com/tools/ch/?app=news&at=ATTOPEN&oid=3868135&l=EN&na=ami062@uit.no&ru=http://asia.tools.euroland.com/tools/subscriptioncentre2/tracker/attachment /? atid = 1280030 & url = SG9uZ0tvbmdcRXRuZXRcMjAyMS0wMlxIS0VYLUVQU18yMDIxMDIwMV85NjA4ODg5XzAuUERG & companycode = KY-9939 & isstockexchangerelease = 1